Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis.
- Year invested 2021
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Company Status Private